Pfizer Unit Beats RICO Claims In Skelaxin Pay-For-Delay Row

Law360, Philadelphia (May 3, 2013, 2:09 PM EDT) -- A Pfizer Inc. unit successfully dodged racketeering claims in Pennsylvania state court Wednesday after a judge partially sustained preliminary objections in a suit accusing the company of conspiring with a Mutual Pharmaceutical Co. Inc. executive to keep generic forms of the muscle relaxant Skelaxin off the market.

A Philadelphia County judge overseeing the case ruled that plaintiffs Hygrosol Pharmaceutical Corp. and Spiridon Spireas had not adequately shown that the alleged scheme directly caused them to lose millions of dollars in potential royalties they claim they were...
To view the full article, register now.